Literature DB >> 24393782

Adrenal cancer in 2013: Time to individualize treatment for adrenocortical cancer?

Constantine A Stratakis1.   

Abstract

2013 was a good year for adrenocortical cancer, as the new knowledge gained holds great promise for patients. Advances were made in genetics, epigenetics, the advent of related technological and bioinformatic tools, and the feasibility of massive screening of people and samples.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24393782     DOI： 10.1038/nrendo.2013.263

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  11 in total

1.  Adrenocortical cancer and IGF2: is the game over or our experimental models limited?

Authors:  Coralie Drelon; Annabel Berthon; Pierre Val
Journal:  J Clin Endocrinol Metab       Date:  2013-01-07       Impact factor: 5.958

2.  Combination chemotherapy in advanced adrenocortical carcinoma.

Authors:  Martin Fassnacht; Massimo Terzolo; Bruno Allolio; Eric Baudin; Harm Haak; Alfredo Berruti; Staffan Welin; Carmen Schade-Brittinger; André Lacroix; Barbara Jarzab; Halfdan Sorbye; David J Torpy; Vinzenz Stepan; David E Schteingart; Wiebke Arlt; Matthias Kroiss; Sophie Leboulleux; Paola Sperone; Anders Sundin; Ilse Hermsen; Stefanie Hahner; Holger S Willenberg; Antoine Tabarin; Marcus Quinkler; Christelle de la Fouchardière; Martin Schlumberger; Franco Mantero; Dirk Weismann; Felix Beuschlein; Hans Gelderblom; Hanneke Wilmink; Monica Sender; Maureen Edgerly; Werner Kenn; Tito Fojo; Hans-Helge Müller; Britt Skogseid
Journal:  N Engl J Med       Date:  2012-05-02       Impact factor: 91.245

3.  An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.

Authors:  R C Ribeiro; F Sandrini; B Figueiredo; G P Zambetti; E Michalkiewicz; A R Lafferty; L DeLacerda; M Rabin; C Cadwell; G Sampaio; I Cat; C A Stratakis; R Sandrini
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 4.  Cell plasticity and heterogeneity in cancer.

Authors:  Nemanja D Marjanovic; Robert A Weinberg; Christine L Chaffer
Journal:  Clin Chem       Date:  2012-12-06       Impact factor: 8.327

Review 5.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

6.  Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.

Authors:  Gislaine Custódio; Guilherme A Parise; Nilton Kiesel Filho; Heloisa Komechen; Cesar C Sabbaga; Roberto Rosati; Leila Grisa; Ivy Z S Parise; Mara A D Pianovski; Carmem M C M Fiori; Jorge A Ledesma; José Renato S Barbosa; Francisco R O Figueiredo; Elis R Sade; Humberto Ibañez; Sohaila B I Arram; Sérvio T Stinghen; Luciano R Mengarelli; Mirna M O Figueiredo; Danilo C Carvalho; Sylvio G A Avilla; Thiago D Woiski; Lisiane C Poncio; Geneci F R Lima; Roberto Pontarolo; Enzo Lalli; Yinmei Zhou; Gerard P Zambetti; Raul C Ribeiro; Bonald C Figueiredo
Journal:  J Clin Oncol       Date:  2013-06-03       Impact factor: 44.544

7.  Molecular screening for a personalized treatment approach in advanced adrenocortical cancer.

Authors:  Maria Cristina De Martino; Abir Al Ghuzlan; Sebastien Aubert; Guillaume Assié; Jean-Yves Scoazec; Sophie Leboulleux; Christine Do Cao; Rossella Libè; Cécile Nozières; Marc Lombès; François Pattou; Francoise Borson-Chazot; Ségolène Hescot; Clement Mazoyer; Jacques Young; Isabelle Borget; Annamaria Colao; Rosario Pivonello; Jean-Charles Soria; Jerome Bertherat; Martin Schlumberger; Ludovic Lacroix; Eric Baudin
Journal:  J Clin Endocrinol Metab       Date:  2013-08-26       Impact factor: 5.958

8.  Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?

Authors:  Cristina L Ronchi; Silviu Sbiera; Ellen Leich; Katharina Henzel; Andreas Rosenwald; Bruno Allolio; Martin Fassnacht
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

9.  Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R.

Authors:  Sébastien Gaujoux; Constanze Hantel; Pierre Launay; Stéphane Bonnet; Karine Perlemoine; Lucile Lefèvre; Marine Guillaud-Bataille; Felix Beuschlein; Frédérique Tissier; Jérôme Bertherat; Marthe Rizk-Rabin; Bruno Ragazzon
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

10.  Mutational landscape and significance across 12 major cancer types.

Authors:  Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962
View more
  6 in total

1.  Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study.

Authors:  Reed I Ayabe; Raja R Narayan; Samantha M Ruff; Michael M Wach; Winifred Lo; Pieter M H Nierop; Seth M Steinberg; R Taylor Ripley; Jeremy L Davis; Bas G Koerkamp; Michael I D'Angelica; T Peter Kingham; William R Jarnagin; Jonathan M Hernandez
Journal:  HPB (Oxford)       Date:  2019-08-22       Impact factor: 3.647

2.  Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.

Authors:  Georgios Antonios Margonis; Yuhree Kim; Jason D Prescott; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Douglas B Evans; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2015-08-19       Impact factor: 5.344

Review 3.  Mouse models of adrenocortical tumors.

Authors:  Kaitlin J Basham; Holly A Hung; Antonio M Lerario; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2015-12-08       Impact factor: 4.102

4.  2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma.

Authors:  Giada Poli; Elisabetta Ceni; Roberta Armignacco; Tonino Ercolino; Letizia Canu; Gianna Baroni; Gabriella Nesi; Andrea Galli; Massimo Mannelli; Michaela Luconi
Journal:  Oncotarget       Date:  2015-03-20

Review 5.  PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors.

Authors:  Annabel S Berthon; Eva Szarek; Constantine A Stratakis
Journal:  Front Cell Dev Biol       Date:  2015-05-20

6.  Genomic landscape of paediatric adrenocortical tumours.

Authors:  Emilia M Pinto; Xiang Chen; John Easton; David Finkelstein; Zhifa Liu; Stanley Pounds; Carlos Rodriguez-Galindo; Troy C Lund; Elaine R Mardis; Richard K Wilson; Kristy Boggs; Donald Yergeau; Jinjun Cheng; Heather L Mulder; Jayanthi Manne; Jesse Jenkins; Maria J Mastellaro; Bonald C Figueiredo; Michael A Dyer; Alberto Pappo; Jinghui Zhang; James R Downing; Raul C Ribeiro; Gerard P Zambetti
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.